CMV p65 antibody
Quick Overview for CMV p65 antibody (ABIN6941309)
Target
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purpose
- Cytomegalovirus p65 (CMV-p65) Antibody
-
Specificity
- Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, CMV is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of CMV disease. An indicator of active CMV infection is needed to facilitate the diagnosis of CMV disease in patients with AIDS or HIV infection. CMV p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.
-
Purification
- 200ug/ml of Ab Purified from Bioreactor Concentrate by Protein A/G.
-
Immunogen
- Recombinant CMV-p65 protein
-
Isotype
- IgG1, kappa
-
-
-
-
Application Notes
-
Positive Control: CMV-infected cells. Tissues.
Known Application: ELISA (For coating use Ab at 1-5 μg/mL, order Ab without BSA), Optimal dilution for a specific application should be determined.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 200 μg/mL
-
Buffer
- Prepared in 10 mM PBS with 0.05 % BSA & 0.05 % azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- Antibody with azide - store at 2 to 8°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.
-
Expiry Date
- 24 months
-
-
- CMV p65 (Cytomegalovirus p65 (CMV p65))
-
Alternative Name
- Cytomegalovirus p65 (CMV-p65)
-
Target Type
- Viral Protein
-
Background
-
Not Known
CMV-infected cells. Tissues.
-
Molecular Weight
- 65kDa
Target
-